HIF1A and metabolic dysfunction-associated steatotic liver disease: In addition, a new HIF1α/PTEN/NF-κBp65 signaling pathway has been identified recently in non-alcoholic fatty liver disease in which HIF-1α promoted fibrosis via PTEN/ p65.